cliexa, a Colorado-based digital health company, acquired ProSkedge.com, an automated surgical scheduling platform. cliexa’s end-to-end virtual health platform offers integrated clinical intake, automated documentation and remote patient monitoring solutions tailored to practices in multiple-subspecialty settings. cliexa has partnered with American College of Cardiology co-developing cardiovascular home health monitoring solutions since 2018.

“With the acquisition of ProSkedge, cliexa’s focus on actionable, meaningful and impactful patient reported outcomes now extends to the pre-clinical care portion of healthcare delivery. The integration of scheduling care enhances the patient experience and removes historic hurdles.” – Dr. Gerald Maccioli, Chairman of Advisory Board at cliexa

ProSkedge has been designed and developed by Dr Lukasz Kowalczyk, practicing gastroenterologist with over 10 years of GI and procedure experience. ProSkedge simplifies, automates, and personalizes the scheduling process for clinics and patients. With this acquisition, cliexa-ProSkedge becomes a true end-to-end platform for clinics and health systems, offering solutions from onboarding to post-procedure monitoring to patients.

“Surgical care continues to grow at a high rate and COVID has pushed care out of hospitals and into higher value ASC’s. As cliexa enables the digital delivery of care across ambulatory clinic settings, ProSkedge adds that expertise into the ASC’s and the surgical space. cliexa now offers healthcare organizations a singular, comprehensive system for high value digital transformation across the entire patient journey.” said Dr. Kowalczyk, who is now a board member at cliexa and Chief Medical Officer for GI and Surgical Automation.

Dr. Kowalczyk added, “Colon cancer screening with colonoscopy is a great example of how we can improve the journey for the patient and practice.  New colon cancer screening guidelines drop the initial screening age to 45-49.  This patient demographic, consisting of about 20M people, has shown a higher demand to manage their healthcare through a digital medium like the cliexa-ProSkedge platform.”

Learn more at cliexa.com/ProSkedge

 

cliexa welcomes Dr Macciolli as chairman of advisory board

cliexa, Integrated Virtual Care Solutions, Announces the Appointment of Gerald Maccioli, MD, MBA, FCCM, FASA as Chairman of its Advisory Board.

Dr. Maccioli practiced anesthesiology and critical care medicine for over 27 years. He completed fellowship training in cardiothoracic anesthesiology and critical care medicine at Duke University following a residency in anesthesiology at the University of North Carolina at Chapel Hill and an internal medicine internship at the University of Oklahoma.

“We are honored to have Dr. Maccioli on board. There could not be a better time to engage with such a successful leader and clinician who will guide us to better develop cliexa focusing on quality and compliance.” said Mehmet Kazgan, Founder and CEO at cliexa.

Prior to joining Envision Healthcare, where he worked as Chief Quality Officer, Dr. Maccioli served as Director of the American Society of Anesthesiologists for North Carolina, President of the Society of Critical Care Anesthesiologists, and Chair of the ASA Section on Education and Research. He has served as the Chair of the American Medical Association (AMA) Committee of Innovators, playing an influential role in developing comprehensive, progressively responsible healthcare reform strategies. Dr. Maccioli also served as a member of the Quality Improvement Advisory Committee and the Committee on Practice Sustainability and Professional Satisfaction.

“Patient reported outcomes (PROMs) are now the ‘coin of the realm’.  Having been involved in healthcare quality reporting for nearly 30 years; cliexa brings not an evolutional product but a disruptive change to actionable, and meaningful PROMs.  I am both honored and excited to join the organization. “ said Dr. Maccioli.

Learn more about Dr. Maccioli’s vision for empowered patient data:

Link to blog: Quality Improvement during a Pandemic: How cliexa Empowers Actionable Data Delivery

 

Frontline health workers are battling not only a public health crisis, but also a workforce crisis. As nursing shortages rise across the country, the most vulnerable communities are hit hardest. These turbulent times have highlighted deep-rooted inequities in health for communities of color, amplifying structural social and economic factors that contribute to poor health outcomes.

Johnson & Johnson Impact Ventures and Village Capital has invited cliexa, alongside fellow health tech entrepreneurs, investors, and public health stakeholders for a virtual startup showcase where 12 startups will pitch their companies.

Learn more about the partnership and register to attend the Startup Showcase on November 12.

As of May 2020, we are proud to announce we have joined the StartUp Health Transformer Community. Joining over 325 global innovators in the healthcare space, StartUp Health organizes and invests in healthcare entrepreneurs in a worldwide community. As a leading healthcare venture fund, their unique approach to seed funding early-stage startups has established a diverse portfolio of entrepreneurs in all facets of health technology to achieve “moonshots.” These Health Moonshots aim to improve global healthcare, ranging from access to care to the ultimate goal of curing disease and cancer.

As their new portfolio company, we share their vision of tackling the access to care moonshot, as highlighted in the recent interview with our Founder & CEO, Mehmet Kazgan. StartUp Health allows cliexa to expand upon our Colorado reach to establish networks with other companies leading innovation in the healthcare industry nationwide. Our shared goal is to improve interoperability among each stakeholder in healthcare. Alongside StartUp Health, our digital screening, EMR integration, and remote monitoring paired with artificial intelligence (AI) will drive access to care regardless of patient’s demographics.

We are proud to join the global army of Health Transformers and are looking forward to the opportunities that will arise from this fruitful partnership.

Come check us out on our Company Profile for more information!

Board Member Announcement (June 2020)

cliexa is pleased to announce Jennifer Bae and Keith Pinter joining cliexa Board of Directors as new board members.

Jennifer Bae is the Managing Director of Innovation for the American College of Cardiology and built the infrastructure for ACC’s Innovation Program from the ground up.  Prior to the ACC, Jennifer worked in global health and pandemic preparedness, including at the Centers for Disease Control and Prevention and the Department of State, where she led Biosecurity Engagement Programs in South and Southeast Asia and served as the Deputy Chief of Bio-engagement globally.  She represented the US Government in a Delegation to the United Nations and crafted pandemic preparedness policies with the interagency.  Prior to her government service, she led best practice research directed at solving strategic and operational issues for the Advisory Board Company.  Jennifer holds a Master’s in Health Services Administration from the University of Michigan School of Public Health.  She speaks Mandarin Chinese, Bahasa (Indonesian), and Spanish.

“ACC built its innovation program around the digital transformation of health care delivery, with remote monitoring as a key aspect of that effort,” Bae said. “cliexa’s platform for collecting patient data both during and between medical office visits, with great attention to information security, supports our shared emphasis on improving patient care by collecting meaningful information and representing it in a way that is actionable to clinicians. I am honored to continue working with cliexa and the other board members to move this innovative vision forward.”

Keith Pinter most recently served as Chief Operating Officer for the $6.5B Physician Services group of the Fortune 500 Envision Healthcare.  Prior to Envision, Keith was Corporate Vice President for Health Management Associates, a Fortune 500 healthcare provider acquired by Community Health Systems in 2014. Previously, Mr. Pinter functioned as President of Lido Capital, XDrive, Epoch internet, and Ameritech. Mr. Pinter received his Presidential MBA from Pepperdine University in 2007. He currently chairs the University of Miami Data Sciences Executive Advisory Board, as well as serving on the boards of Accolite, Burst IQ, and Bold Destiny.

“I’m excited to assist the board and leadership team in unlocking the tremendous value which cliexa has purposefully and innovatively engineered with its unique platform, enabling providers to make informed decisions more effectively and having a holistic view of patient-reported data. cliexa’s unique platform with clinician-centric workflows, AI-driven predictive risk models and compliance framework has the potential to make a substantial difference for many of the specialties, especially so for those chronic diseases.”, Keith Pinter said,

“cliexa just got two of the best board members and advisor with great experience in healthcare innovation, clinical technology development, and healthcare operations. We are extremely lucky to have Jennifer’s and Keith’s wisdom to accelerate cliexa’s growth moving forward,” said Mehmet Kazgan, Founder and CEO of cliexa.